Dassault Systemes BIOVIA

European software arms of global conglomerates (like Dassault Systemes BIOVIA) provide the deeply validated, rigidly structured LIMS required by legacy Big Pharma manufacturing sites.

Country: France

Commercial Enterprise ELN

Coverage

	CN	EU	IN	US
analytics-pat	✓	✓	—	✓
digital-it	✓	✓	✓	✓

Regulatorsfdaemanmpa

Verifiable facts

Fact	Value	Source
Funding	Dassault Systèmes does not report specific funding rounds for the BIOVIA brand as it is an operating brand of the publicly traded company Dassault Systèmes.	investor.3ds.com · 3ds.com · itnewsonline.com
Headquarters	San Diego, California, USA	3ds.com
Certification	ISO 9001:2015 (3DEXPERIENCE platform cloud apps), ISO/IEC 27001:2013 (ScienceCloud)	blog.3ds.com · discover.3ds.com · intuitionlabs.ai · 3ds.com
Regulatory approval	Products designed for FDA 21 CFR Part 11, GxP, and Annex 11 compliance.	blog.3ds.com · discover.3ds.com · intuitionlabs.ai · 3ds.com
Headcount	Dassault Systèmes total headcount is 25,967 as of December 31, 2025. Individual BIOVIA headcount is not disclosed separately. medium confidence	investor.3ds.com · appsruntheworld.com
Revenue	Life Sciences software revenue (includes MEDIDATA and BIOVIA) was €1.08 billion for the full year 2025. BIOVIA revenue is not disclosed separately.	investor.3ds.com · live.euronext.com

Independent sources: 3ds.com · appsruntheworld.com · blog.3ds.com · discover.3ds.com · intuitionlabs.ai · investor.3ds.com · itnewsonline.com · live.euronext.com

Technologies

Name	Cluster	Risk
Laboratory execution systems (LES)	analytics-pat	Low	→
LIMS/ELN for bioproduction	digital-it	Low	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.